Effects on cervical cytology screening productivity associated with implementation of the BD FocalPoint™ guided screener imaging system

Acta Cytologica

Volumn 57, Issue 2, 2013, Pages 147-152

  Sweeney, Brenda J ^a   Wilbur, David C ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Automation; Cervical cytology; Pap test; Workload

Indexed keywords

ARTICLE; CYTOTECHNOLOGIST; FEMALE; FOLLOW UP; HUMAN; IMAGING SYSTEM; PRIORITY JOURNAL; PRODUCTIVITY; SCREENING TEST; UTERINE CERVIX CYTOLOGY; WORKLOAD; CHI SQUARE DISTRIBUTION; COMPUTER ASSISTED DIAGNOSIS; EQUIPMENT; EQUIPMENT DESIGN; LABORATORY AUTOMATION; LEARNING CURVE; MASS SCREENING; PATHOLOGY; PERSONNEL MANAGEMENT; PREDICTIVE VALUE; TIME; UNIVERSITY HOSPITAL; UTERINE CERVIX; UTERINE CERVIX DISEASE; VAGINA SMEAR;

AUTOMATION, LABORATORY; CERVIX UTERI; CHI-SQUARE DISTRIBUTION; EFFICIENCY; EQUIPMENT DESIGN; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; LEARNING CURVE; MASS SCREENING; PERSONNEL STAFFING AND SCHEDULING; PREDICTIVE VALUE OF TESTS; TIME FACTORS; UTERINE CERVICAL DISEASES; VAGINAL SMEARS; WORKLOAD;

MLCS; MLOWN;

EID: 84873597480     PISSN: 00015547     EISSN: 19382650     Source Type: Journal    
DOI: 10.1159/000345569     Document Type: Article

References (19)

1. Gustafsson L, Pontén J, Zack M, Adami HO: International incidence rates of invasive cervical cancer after introduction of cytological screening. Cancer Causes Control 1997; 8: 755-763. (Pubitemid 27404646)
2. Birdsong GG: Cytotechnology training at risk: cytotechnology school closures could lead to critical shortage-American Society of Cytopathology. http://pdffinder.net/CYTOTECHNOLOGY-TRAININGENDANGERED. html (accessed December 7, 2011).
3. Commission on Accreditation of Allied Health Education Programs: Cytotechnology accredited program list. 2009. http://www.caahep.org/Find-An- Accredited-Program/(accessed September 18, 2012).
4. American Society of Clinical Pathology: Board of Certification examination statistics 2010. http://www.ascp.org/PDF/BOC-PDFs/Statistics/ ExaminationStatistics2010.aspx. 2011 (accessed September 18, 2012).
5. Balachandran I, Friedlander M: Cytology workforce study: a report of current practices and trends in New York State. Am J Clin Pathol 2011; 136: 108-118.
6. Saslow D, Solomon D, Lawson H, Killackey M, Kulasingam S, Cain J, Garcia F, Moriarty A, Waxman A, Wilbur D, Wentzensen N, Downs L, Spitzer M, Moscicki A, Franco E, Stoler M, Schiffman M, Castle P, Myers E: American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. Am J Clin Pathol 2012; 137: 516-542.
7. Brotherton JM, Fridman M, May CL, Chappell G, Saville AM, Gertig DM: Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study. Lancet 2011; 377: 2085-2092.
8. Evans KK, Tambouret RH, Evered A, Wilbur DC, Wolfe JM: Prevalence of abnormalities influences cytologists' error rates in screening for cervical cancer. Arch Pathol Lab Med 2011; 135: 1557-1560.
9. Patten SF, Lee JSJ, Wilbur DC, Bonfiglio TA, Colgan TJ, Richart RM, Cramer H, Moinuddin S: The AutoPap 300 QC System multicenter clinical trials for use in quality control rescreening of cervical smears. 1. A prospective intended use study. Cancer Cytopathol 1997; 81: 337-342. (Pubitemid 28283508)
10. Patten SF, Lee JSJ, Wilbur DC, Bonfiglio TA, Colgan TJ, Richart RM, Cramer H, Moinuddin S: The AutoPap 300 QC System multicenter clinical trials for use in quality control rescreening of cervical smears. 2. Prospective and archival sensitivity studies. Cancer Cytopathol 1997; 81: 342-347.
11. Wilbur DC, Prey MU, Miller WM, Pawlick GF, Colgan TJ: The AutoPap system for primary screening in cervical cytology: comparing the results of a prospective, intendeduse study with routine manual practice. Acta Cytol 1998; 42: 214-220.
12. Wilbur DC, Parter EM, Foti JA: Locationguided screening of liquid-based cervical cytology specimens: a potential improvement in accuracy and productivity is demonstrated in a preclinical feasibility trial. Am J Clin Pthol 2002; 118: 399-407. (Pubitemid 37046338)
13. Biscotti CV, Dawson AE, Bziura B, Galup L, Darragh T, Rahemtulla A, Wills-Frank L: Assisted primary screening using the automated ThinPrep imaging system. Am J Clin Pathol 2005; 123: 281-287. (Pubitemid 40194092)
14. Wilbur DC, Black-Schaffer WS, Luff RD, Abraham KP, Kemper C, Molina JT, Tench WD: The Becton Dickinson FocalPoint GS Imaging System: clinical trials demonstrate significantly improved sensitivity for the detection of important cervical lesions. Am J Clin Pathol 2009; 132: 767-776.
15. Chivukula M, Mauser N, Dabbs DJ, White S, Dawson A, Underwood D, Austin RM: Relative impact of the ThinPrep imaging system (TIS) as a quality tool and a productivity tool in two academic medical centers (abstract). Cancer Cytopathol 2006: 108: 388.
16. Food and Drug Administration: How laboratorians can safely calculate workload for FDA-approved semi-automated gynecologic cytology screening devices. 2010. http://www.fda.gov/MedicalDevices/Safety/Aler tsandNot ices/TipsandAr t icleson DeviceSafety/ucm220292.htm (accessed December 7, 2011).
17. Elsheikh TM, Austin RM, Chhieng DF, Miller FS, Moriarty AT, Renshaw AA: American Society of Cytopathology workload recommendations for automated pap test screening: developed by the Productivity and Quality Assurance in the Era of Automated Screening Task Force. Diagn Cytopathol 2012, E-pub ahead of print.
18. Renshaw AA, Elsheikh TM: Predicting screening sensitivity from workload in gynecologic cytology: a review. Diagn Cytopathol 2011; 39: 832-836.
19. Renshaw AA, Elsheikh TM: Low grade squamous intraepithelial lesion, epithelial cell abnormality-adjusted workload, and the ThinPrep imaging system. Diagn Cytopathol 2012; 40: 698-700.